Lehrstuhl für Urologie

Renal transplantation in urinary diversions Nierentransplantation in Harnableitungen (2019) Sikic D, Richterstetter M, Wullich B, Apel H Journal article, Review article Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2) (2019) Merten R, Ott O, Haderlein M, Bertz S, Hartmann A, Wullich B, Keck B, et al. Journal article Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars Series (2019) Seiler R, Black PC, Williams SB, Goebell P, Kamat AM, Nawroth R, Schmitz-Dräger BJ Journal article, Review article 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients (2019) Schmidkonz C, Cordes M, Goetz TI, Prante O, Kuwert T, Ritt P, Uder M, et al. Journal article Urology vision 2025 Urologie Vision 2025 (2019) Klotz T, Zumbe J, Wullich B Journal article, Editorial Megaprepuce: presentation of a modified surgical technique with excellent cosmetic and functional results (2019) Hirsch K, Schwaiger B, Kraske S, Wullich B Journal article Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative review (2019) Kunath F, Goebell P, Wullich B, Sikic D, Kahlmeyer A Journal article, Review article sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro (2019) Tsaur I, Hüsch T, Jüngel E, Schneider F, Schneider M, Haferkamp A, Thomas C, et al. Journal article New horizons in bladder cancer research (2019) Boormans JL, Zwarthoff EC, Black PC, Goebell P, Kamat AM, Nawroth R, Seiler R, et al. Journal article, Review article Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab (2019) Eckstein M, Erben P, Kriegmair MC, Worst TS, Weiss CA, Wirtz RM, Wach S, et al. Journal article